Abstract:Background: Gynostemma pentaphyllum (Thunb.) Makino has been linked to a numbers of pharmacological benefits, including hepatoprotective, anti-inflammatory, antioxidative, and antihyperlipidemic activities. Gypenoside XLVI (Gyp XLVI) was a significant triterpenoid saponin reported from a sweet-taste varietas G. pentaphyllum, which has inhibitory effects and causes apoptosis on human hepatocytes and hepatoma cells. background: Gynostemma pentaphyllum (Thunb.) Makino has been linked to numbers of pharmacological benefits, including hepatoprotective, anti-inflammatory, antioxidative, and anti-hyperlipidemic activities. Gypenoside XLVI (Gyp XLVI) is a significant dammarane-type triterpene saponin from the sweet-taste G. pentaphyllum, which has inhibitory effects and causes apoptosis on human hepatocytes and hepatoma cells. Methods: A quick, precise, and sensitive method for the quantification and pharmacokinetic research of Gyp XLVI in rats was developed utilizing UPLC-MS/MS. When extracting blood samples, protein was precipitated using methanol. An internal standard (IS) was employed, which was tolbutamide. For the chromatographic separation, a C18 column (Waters Acquity) was used with mobile phases as 0.1% formic acid and acetonitrile. Multiple reaction monitoring was used as MS detection manner with electrospray ionization in negative mode. Results: Gyp XLVI had good linearity in the 1.36‒1000.00 ng/mL concentration range. The intra- day and inter-day precisions (RSD%) and accuracy (RE%) were less than 12.7% or 8.29%, respectively. Gyp XLVI’s extraction recovery ranged from 89.5% to 104.2%. The matrix effects ranged from 75.3%‒94.3%. The outcomes of matrix interference and recovery investigations complied with the necessary variability limitations. After three hours at room temperature (25°C), 24 hours in an auto-sampler (4°C), three freeze-thaw cycles, and 30 days of storage at -20°C, the analyte in rat plasma remained stable. Gyp XLVI pharmacokinetic investigations and quantification were conducted using the validated method. The AUC0-∞ values for intravenous administration (1 mg/kg) and oral administration (10 mg/kg) were 2213.9 ± 561.5 ng·h/mL and 1032.8 ± 334.8 ng·h/mL, respectively. Gyp XLVI had a half-life (t1/2z) of 2.5 ± 0.4 h in the rats after intravenous injection and 4.2 ± 0.9 h after oral administrations. Gyp XLVI had a comparatively low oral bioavailability of 4.56%. Conclusion: This is the first time that Gyp XLVI’s pharmacokinetic properties have been investigated through various administration routes. These findings will aid in our understanding of how Gyp XLVI was metabolized in rats and how it behaved pharmacologically in vivo.

Metabolites in Rat Urine after Orally Administrating Gossypetin-8-o-β-d-glucuronide

Analysis of Rat Serum after Orally Administrating Gossypetin-8-o-glucuronide

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Identification of Metabolites of Geniposide in Rat Urine Using Ultra-Performance Liquid Chromatography Combined with Electrospray Ionization Quadrupole Time-of-flight Tandem Mass Spectrometry.

Metabolism of Genipin in Rat and Identification of Metabolites by Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Tandem Mass Spectrometry

[Ginkgo Flavones in in Vitro Metabolism and Its Clinical Application].

Studies on Determination and in Vitro Metabolism of Ginkgolides and Bilobalide in Rat Liver Microsomes by Using HPLC-ELSD Method

[Metabolite Fingerprint and Biomarkers Identification of Rat Urine after Dosed with Ginsenoside Rg3 Based on Ultra High Performance Liquid Chromatography/time-of-flight Mass Spectrometry (UPLC/TOF-MS)].

Identification of Ginkgolic Acid (15:1) Metabolites in Rats Following Oral Administration by High-Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry

Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglycoside of Tripterygium wilfordii Hook. f.

Pharmacokinetic Studies of Gypenoside XLVI in Rat Plasma using UPLC-MS/MS Method

[Pharmacokinetics of Gypenoside XVⅡ in Rats].

In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry

Identification of 3′,4′-Dimethoxy Flavonol-3-β-d-Glucopyranoside Metabolites in Rats by Liquid Chromatography-Electrospray Ionization Ion Trap Mass Spectrometry

A validated HPLC-MS/MS method for determination of genipin-1-o-glucuronic acid in rat plasma after dministration of genipin and its application to a pharmacokinetic study

In vivo pharmacokinetics of Glycyrrhiza uralensis polysaccharides

Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry

Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study

A liquid chromatography‐tandem mass spectrometry method for comprehensive determination of metabolites in the purine pathway of rat plasma and its application in anti‐gout effects of Lycium ruthenicum Murr.

Pharmacokinetics, tissue distribution, and excretion study of GL‐V9 and its glucuronide metabolite 5‐O‐glucuronide GL‐V9 in Sprague–Dawley rats

Metabolic profiles and pharmacokinetics of goitrin in rats through liquid chromatography combined with electrospray ionization-tandem mass spectrometry.